ROSA MARÍA
AYALA DÍAZ
Profesora titular de universidad
University of Texas MD Anderson Cancer Center
Houston, Estados UnidosPublicaciones en colaboración con investigadores/as de University of Texas MD Anderson Cancer Center (3)
2023
-
Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study
The Lancet, Vol. 401, Núm. 10373, pp. 269-280
2013
-
Inhibition of related JAK/STAT pathways with molecular targeted drugs shows strong synergy with ruxolitinib in chronic myeloproliferative neoplasm
British Journal of Haematology, Vol. 161, Núm. 5, pp. 667-676
-
Proteomic analysis reveals heat shock protein 70 has a key role in polycythemia Vera
Molecular Cancer, Vol. 12, Núm. 1